Viewing Study NCT01517750


Ignite Creation Date: 2025-12-24 @ 4:55 PM
Ignite Modification Date: 2025-12-27 @ 9:14 PM
Study NCT ID: NCT01517750
Status: COMPLETED
Last Update Posted: 2015-06-24
First Post: 2012-01-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Predict the Need for Humidification Use and Comparison of the Effect of ThermoSmartâ„¢ and no Humidification on Adherence
Sponsor: Fisher and Paykel Healthcare
Organization:

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2015-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Despite the effectiveness of continuous positive airway pressure (CPAP) in abolishing upper airway obstruction, acceptance of and adherence with therapy has been sub-optimal. One of the only technological advancements shown to increase adherence is heated humidification, now considered part of conventional CPAP therapy in some countries. ThermoSmartâ„¢ is a unique technology developed by Fisher \& Paykel Healthcare which utilises a heated breathing tube to deliver optimal humidity in all environments. ThermoSmart has been shown to be superior to conventional humidification in reducing side effects, condensation and titrated pressure as well as increasing total sleep time. However, improved humidity delivery has not lead to significantly increased adherence in unselected obstructive sleep apnea (OSA) patients.

A total of 80 patients diagnosed with OSA but naive to CPAP use will be randomized into a single blind, randomized, parallel-arm trial to determine whether the the use of heated humidification will impact therapy adherence.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: